Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001624480-15-000002
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-03-13 15:59:57
Reporting Period:
2015-03-11
Filing Date:
2015-03-13
Accepted Time:
2015-03-13 15:59:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
887226 Perceptron Inc PRCP Optical Instruments & Lenses (3827) 382381442
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1239302 Sylvia Smith 47827 Halyard Dr
Plymouth MI 48170
Vice President & Cao No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Stock Option Acquisiton 2015-03-11 1,500 $2.80 26,807 No 4 M Direct
Common Stock Disposition 2015-03-11 1,500 $11.90 25,307 No 4 S Direct
Stock Option Acquisiton 2015-03-11 3,000 $6.14 28,307 No 4 M Direct
Common Stock Disposition 2015-03-11 3,000 $11.90 25,307 No 4 S Direct
Stock Option Acquisiton 2015-03-12 1,000 $10.55 26,307 No 4 M Direct
Common Stock Disposition 2015-03-12 1,000 $12.00 25,307 No 4 S Direct
Stock Option Acquisiton 2015-03-13 2,000 $5.70 27,307 No 4 M Direct
Common Stock Acquisiton 2015-03-13 2,000 $11.65 25,307 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Options (right to buy) Disposition 2015-03-11 1,500 $0.00 1,500 $2.80
Common Stock Employee Stock Options (right to buy) Disposition 2015-03-11 3,000 $0.00 3,000 $6.14
Common Stock Employee Stock Option (right to buy) Disposition 2015-03-12 1,000 $0.00 1,000 $10.55
Common Stock Employee Stock Option (right to buy) Disposition 2015-03-13 2,000 $0.00 2,000 $5.70
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2019-03-01 No 4 M Direct
0 2021-08-31 No 4 M Direct
0 2023-09-02 No 4 M Direct
0 2022-09-03 No 4 M Direct
Footnotes
  1. On 03/02/2009, the reporting person was granted an option to purchase 6,000 shares of Common Stock under the 2004 Stock Incentive Plan, an exempt plan. The shares are exercisable in four equal installments beginning on March 2, 2010 at an exercise price equal to the fair market value of the Company's Common Stock as of March 2, 2009, expiring ten years from the grant date.
  2. On 09/01/2011, the reporting person was granted an option to purchase 4,000 shares of Common Stock under the 2004 Stock Incentive Plan, an exempt plan. The shares are exercisable in four equal installments beginning on September 1, 2012 at an exercise price equal to the fair market value of the Company's Common Stock as of September 1, 2011, expiring ten years from the grant date.
  3. On 09/03/2013, the reporting person was granted an option to purchase 4,000 shares of Common Stock under the 2004 Stock Incentive Plan, an exempt plan. The shares are exercisable in four equal installments beginning on September 3, 2014 at an exercise price equal to the fair market value of the Company's Common Stock as of September 3, 2013, expiring ten years from the grant date.
  4. On 09/04/2012, the reporting person was granted an option to purchase 4,000 shares of Common Stock under the 2004 Stock Incentive Plan, an exempt plan. The shares are exercisable in four equal installments beginning on September 4, 2013 at an exercise price equal to the fair market value of the Company's Common Stock as of September 4, 2012, expiring ten years from the grant date.